This time, the entire world is adrift from the eruption of perhaps the most devastating pandemic in current history. It has disrupted our work and put our lives at great risk. The clinical administration structure has been faced with authoritative trials, but in the absence of confidence in the matter of substance dependence, clinical supply has become a critical issue. Associations empower to help and keep society moving forward in the best way they can.
The scene of the COVID-19 pandemic reveals inadequacies in the size of the stock organization within the clinical administration structure. The 7PLUS COIN is proposed to improve the clinical administration of the head storage network and to follow the collaborative transfer of COVID-19 clinical materials, for example, face coats, gloves, etc., to areas of great need. During the early phase of the Covid pandemic, countries around the world were severely affected and various economies were suffering from inefficient store chain actions. Given the basic need for efficiency in clinical stock organization systems, blockchain development is well-suited to address the prominent pitfalls revealed by the COVID-19 pandemic.
The clinical ingredient supply has a place where most ingredients are taken seriously because of their safety recommendations. These supplies are regularly used in workrooms or crisis facility wards for the neatness and safety of staff and patients. They are washable or unimportant. This example of clinical kit combines discreet clothing, covers, shrouds, calm curtains, and clothing pieces of various sizes. The clinical supplies used in the central ward combine sheets, clothing, sleeping pads, covers and tissues.
Penn asia is developing a high-level asset called the 7plus coin (sv7 coin), which will be used as a utility token for basic trading, serving, and following all materials to clinical wear. The Coronavirus pandemic eruption revealed flaws in the measurement of the chain of stores in the structure of clinical considerations. The 7plus coin is proposed to increase the clinical consideration store chain of the chiefs and the following associations of dynamic stamped clothing, underwear and apples of outstanding clinical materials such as face coverings, gloves, ppe clothing, temperature control of newborns blanckets, etc.
The Advancement DryDye is a measure of polyester surface shade that uses no water, less engineered substances, and half less energy than standard surface shading processes1. Instead of using water as the shade medium, the shade is mixed to the surface using pressed carbon dioxide. Additionally, the 7 Plus Coin project is making improvements to this cutting edge.
7PLUS Coin was created to renew and advance the stable trade between the Yeh Group association and many future clinical companies around the world. The company comes from authentic pharmaceutical associations such as US WorldMeds, Elorac Inc., Pacira Pharmaceuticals, Inc., Putney / Dechra, Clinipace Worldwide, and various others.
Problems & Solutions
1. Poor management and tracking of pharmaceutical and health care supply chains
This is a huge problem during the heat of the coronavirus pandemic. Government agencies find it very difficult to track the volume and location of important supplies. This has had a devastating effect on limiting the spread of the virus and protecting the population.
Solution
The supply chain that supports blockchain enables unchanging, transparent and efficient tracking of medical supplies from the point of production to the consumer. Throughout the supply chain, blockchain helps provide information, transparency, evidence, accuracy. with this information, the risks associated with the supply chain will be minimized for all parties; inclusive producers and consumers.
2. Lack of confidence and public panic
When it became known that face masks from China to Europe (UK, China, Ireland, etc.) had been contaminated, it caused panic among the population. Public panic will do more harm than good as we try to contain the outbreak of this pandemic.
Solution
A blockchain system that securely tracks and verifies materials, production volume, availability, and quality will significantly increase public confidence in ingredients and even pharmaceuticals. The blockchain system will allow fact-based information sharing. Tracing the origin and end point of medical textile materials will reduce unnecessary exposures and legal risks.
3. Lack of ease of payment
Traditionally, cross-border payments have been accompanied by high banking fees and time delays due to physical distance. This is really not helping the fight to combat the spread of the coronavirus pandemic. Delays in processing transactions prevent the transportation of medical textile materials to where they are needed. In addition, large multinational corporations have difficulty tracking many business transactions and accounts financially.
Solution
To address the lack of ease of payment in the COVID-19 medical supply kit supply chain, one can adopt a digital asset payment system to make it easier for producers and buyers. A great example of such a digital asset is the 7PLUS COIN created by the Yeh Group company.
4. Counterfeit products
The counterfeit drug market is worth $ 75 billion annually, including medical textile supplies. On July 24, 2020, INTERPOL reported a global seizure of counterfeit medical products related to Covid-19. Items seized included 34,000 fake and substandard face masks. At a time when the supply of standard medical textiles is so important, we cannot allow the spread of counterfeit goods to the global market.
Solution
With the decentralized and immutable logging features that blockchain offers, we are able to track each COVID-19 textile medical supply journey to verify its authenticity or deficiency.
The Global Market for Breathable Waterproof Textiles
According to ResearchAndMarket.com, the global waterproof breathable textile market accounted for $ 1.7 billion in 2019. The market is expected to grow to $ 3.10 billion by 2027, with a CAGR of 7.7% in the forecast period. Increasing preference for high performance and comfortable materials as well as increased awareness of fitness are the main drivers causing market growth. This waterproof, water-resistant textile is produced by combining and stacking cotton threads. Critical analysis of the fabric reveals that the membrane has favorable growth due to its excellent mechanical properties and water resistance. The membrane is made of a very thin film made of polymer and is designed to be very resistant to water penetration but to allow the flow of water vapor.
Supply Chain Market Players
There are three key players in the covid-19 medical textile supply chain market. These key players have been affected by the supply of counterfeit covid-19 medical textiles.
Seller: A covid-19 medical textile material seller can be a manufacturer, supplier, retailer or others. It is a profit-generating entity that relies on the quality of the products sold and the reliability and trustworthiness of the brand names developed over the years. According to the Organization for Economic Co-operation and Development (OECD), "An important component on which the commercial supply of counterfeit products relies on is a 'free ride' on the economic value associated with certain intellectual property." Counterfeit products misuse the manufacturer's brand name, which damages the reputation and profitability of the business. In addition, the damage to consumer confidence has further reduced the customer base in each business entity.
Buyer: Buyers are being tricked into buying fake medical textile supplies for COVID-19, thus putting everyone's life at risk by using the material. Consumer confidence in the online retail space is undermined by the inability to check and differentiate between genuine and fake medical textile materials. The element of trust is very important when buying goods, and is often taken advantage of.
Mediator: Mediators often come in the form of law enforcement agencies that attempt to identify and confiscate counterfeit products (covid-19 textiles, medical supplies). These mediators face enormous costs for tracking and investigating the production, procurement, movement and sale of these counterfeit covid-19 textile medical supplies.
YEH'S GROUP TECHNOLOGY
Yeh Group uses the special Drydye waterless technology for the production of covid-19 medical textiles. Only 6 manufacturing companies in the world use DryDye technology. However, Yeh Group is the only one with a one-stop service from yarn spinning, weaving, waterless dyeing and printing with advanced dry dyes to avoid water pollution. Apart from the advanced drydye technology, Yeh Group also uses blockchain technology in its supply chain process to enable more transparent and accurate tracking of medical textile products. The blockchain protocol allows retailers to verify the authenticity of all covid-19 medical equipment that comes from the Yeh Group.
Token Allocation
7PLUS COIN was developed to enhance and promote seamless transactions between Yeh Group companies and tens of hundreds of future medical companies worldwide. The companies range from leading pharmaceutical companies such as US WorldMeds, Elorac Inc., Pacira Pharmaceuticals, Inc., Putney / Dechra, Clinipace Worldwide, and many others.
7PLUS Coin is an ERC-20 utility token built on the Ethereum blockchain. It has a total supply of 200 million tokens, and becomes $ 0.1 per SV7 coin each during private and public sales.
The token symbol, represented as SV7 has the following allocations:
7plus token sale
The token sale will be in batches and will take place simultaneously with several marketing auctions. It will follow a two-round token sale offering period to allow investors at various stages to contribute to the token sale. The total supply token is 200,000,000, and the price per token is $ 0.1. The total funds expected to be raised are $ 20 million. The first sale will be held from 12 February 2021 to 28 February 2021. Those who buy within this period will receive a 25% bonus on their purchases. The second phase of the sale will take place between April 1, 2021 and May 31, 2021. People who buy in the first two weeks of the sale will receive a 15% bonus. If you buy within 3-4 weeks of the sale, you will receive a 10% bonus. Also, those who buy within 5-8 weeks will receive a 5% bonus. All sales will end on May 31, 2021.
It is scheduled as follows:
The token sale after reaching the soft cap and hard cap as the peak, the funds realized will be used as follows:
Allocation of Funds
The token sale after reaching the soft cap and hard cap as the peak, the funds realized will be used as follows:
For information regarding this project see the link below:
Website: https://7pluscoin.com/
Facebook: https://www.facebook.com/SV7PlusCoin-103483088392823
Telegram: https://t.me/English7plus
Twitter: https://twitter.com/7pluscoin
Youtube: https://www.youtube.com/channel/UCqqoJ6ai6yLzmcFw_ZxUfJw
Media: https://seventhcoin7.medium.com/
Author: Homio
Bitcointalk: https://bitcointalk.org/index.php?action=profile;u=2865336
My ETH address https://www.bitenium.com: 0xF87015a94f70D4b0912614b895F2f2d5182815e4
Masks are no longer needed after the pandemic. But has the pandemic changed you?
Downvoting a post can decrease pending rewards and make it less visible. Common reasons:
Submit
The pandemic has certainly become a severe test for all of us. But at the same time, we realized how strong and how much humanity can unite. It has also become obvious to many people that the Internet is now a very effective way to communicate, work, and even buy goods. It is very difficult to buy the necessary medicines and medical masks when you are at home and are afraid of contracting a little-studied disease. We bought syringes and masks online, which turned out to be a very convenient and effective method of shopping. And I'm glad the pandemic has changed our consciousness so much.
Downvoting a post can decrease pending rewards and make it less visible. Common reasons:
Submit